Bioinformatics Market Size is Projected to Hit 24.07 Bn by 2028, With at a 12.1% CAGR by 2022-2028 | Brandessence Market Research


According to a comprehensive research report by Brandessence Market Research (BMRC), “Bioinformatics Market Size, Share, And Trends Analysis Report By Product (Sequence Analysis Platform, Sequence Alignment Platforms, Structural & Functional Analysis Platforms, Sequence Manipulation Platforms), By Application (Drug Development, Protein Function Analysis, Gene Therapy, Molecular Genomics, Personalized Medicine) Based On Region, And Segment Forecasts, 2022 – 2028″. The Bioinformatics Market was valued at USD 10.82 Billion in 2021 and is expected to reach USD 24.07 Billion by 2028, amplifying with a CAGR of 12.1% over 2022-2028.

Bioinformatics Market Overview:

Bioinformatics, a multidisciplinary field that combines biology, computer science, and information technology, has emerged as a pivotal player in the life sciences industry. It encompasses the storage, analysis, and interpretation of biological data, enabling scientists to extract valuable insights and accelerate advancements in genomics, proteomics, and other branches of life sciences. In this article, we delve into the current state of the bioinformatics market, exploring its size, market share, trends, drivers, opportunities, threats, and recent industry developments.

Bioinformatics Market Scope-

Report Metric


Bioinformatics Market Revenue Forecast in 2028

USD 24.07 Billion

Market Size in 2021

USD 10.82 Billion

Market Growth Rate

CAGR of 12.1% from 2022 to 2028

Base Year


Study Period


Key Players/Companies

Life Technologies, Affymetrix, Bio-Rad Laboratories, Agilent Technologies, Thermo Fisher Scientific, Eurofins Scientific, Illumina and Others.

Get Free Sample PDF Brochure:

Bioinformatics Segmentation:

By Product:

  • Sequence Analysis Platform
  • Sequence Alignment Platforms
  • Structural & Functional Analysis Platforms
  • Sequence Manipulation Platforms

By Application:

  • Drug Development
  • Protein Function Analysis
  • Gene Therapy
  • Molecular Genomics
  • Personalized Medicine

Trends and Drivers:

1. Advancements in Next-Generation Sequencing (NGS):

The adoption of NGS technologies has witnessed an upswing, driving the demand for bioinformatics solutions to handle the deluge of data generated. This trend is anticipated to persist as NGS becomes more accessible and cost-effective.

2. Rising Focus on Personalized Medicine:

The shift towards personalized medicine, tailoring treatments based on an individual’s genetic makeup, is bolstering the demand for bioinformatics tools. This approach holds immense potential in optimizing patient outcomes and minimizing adverse effects.

3. Integration of Artificial Intelligence (AI) and Machine Learning (ML):

AI and ML are revolutionizing data analysis, allowing for more accurate predictions and discoveries. Bioinformatics platforms leveraging these technologies are gaining traction for their ability to discern complex patterns within biological datasets.

Eminent industry players profiled in the Bioinformatics Market report include:

  • Life Technologies
  • Affymetrix
  • Bio-Rad Laboratories
  • Agilent Technologies
  • Thermo Fisher Scientific
  • Eurofins Scientific
  • Illumina
  • Others.

Browse In-depth Market Research Report (300 Pages) on Bioinformatics Market:

Bioinformatics Market Dynamics:

Bioinformatics is a fusion of biological sciences and information technology, playing a crucial role in the management of biological data within medical research and drug development. It leverages computer software tools for tasks like database creation, data management, warehousing, mining, and networking. The escalating investments in drug discovery are acting as a catalyst for market expansion. Furthermore, the inclination towards collaborative efforts with genetics research institutions stands as a pivotal factor driving the significant market share in medical biotechnology. This field encompasses a wide array of specialized domains including structural genomics, functional genomics, DNA microarrays, comparative genomics, and medical information management. The escalating demand for integrated bioinformatics systems in proteomics and genomics is also bolstering market growth. Genomics, as an application, dominates the bioinformatics industry. Recent trends in the industry include an upsurge in mergers, acquisitions, and a surge in new product innovations. Noteworthy growth opportunities lie in technologies like nanopore sequencing. However, challenges persist in the form of a shortage of skilled professionals and the high implementation costs associated with bioinformatics software.

Opportunities and Threats in the Industry:


  1. Emerging Markets: Untapped regions like Asia-Pacific offer significant growth opportunities due to expanding research activities and government initiatives.
  2. Drug Repurposing: Bioinformatics plays a pivotal role in identifying existing drugs that can be repurposed for new therapeutic purposes, presenting a cost-effective approach to drug discovery.


  1. Data Privacy and Security Concerns: With the surge in biological data, ensuring the confidentiality and integrity of sensitive information remains a critical challenge.
  2. Regulatory Hurdles: Adhering to evolving regulatory frameworks and compliance standards can be a hurdle for companies operating in this space.

Market Industry Developments:

Recent developments in the bioinformatics market include partnerships between academic institutions and industry players, mergers and acquisitions, and the launch of innovative software solutions aimed at streamlining data analysis workflows.

Report Scope:

This article provides a comprehensive overview of the bioinformatics industry, including its current size, market share, key players, trends, drivers, opportunities, threats, and recent industry developments. It aims to offer valuable insights to stakeholders, researchers, and industry enthusiasts keen on understanding the dynamics of this rapidly evolving field.

Porter’s Five Forces Analysis:

1. Threat of New Entrants:

Low Threat: The bioinformatics market requires a substantial investment in technology, research, and development. Additionally, there are high regulatory barriers due to the sensitive nature of biological data. Existing companies have established brand recognition and a strong foothold in the industry, making it difficult for new entrants to gain market share.

2. Bargaining Power of Suppliers:

Moderate Threat: Suppliers in the bioinformatics market mainly provide hardware, software, and data management solutions. While there are several suppliers in the market, some specialized components may have limited sources. However, the presence of multiple suppliers reduces their individual bargaining power.

3. Bargaining Power of Buyers:

Moderate to High Threat: Buyers in the bioinformatics market, which include research institutions, pharmaceutical companies, and academic organizations, have a reasonable degree of bargaining power. They can switch between bioinformatics providers based on factors like pricing, service quality, and technological capabilities.

4. Threat of Substitutes:

Low Threat: There are limited substitutes for bioinformatics in terms of effectively managing and analyzing biological data. Traditional methods of data analysis are less efficient and cannot handle the large volumes of data generated in fields like genomics and proteomics.

Purchase Copy of This Research Report @:

  1. Competitive Rivalry within the Industry:

High Threat: The bioinformatics market is highly competitive, with numerous well-established players vying for market share. Key companies like Illumina, Thermo Fisher Scientific, and Qiagen have a significant presence and engage in constant innovation to maintain their competitive edge. Additionally, the market is characterized by a continuous influx of startups and technological advancements.


The bioinformatics market is poised for remarkable growth, driven by technological advancements, increasing research endeavors, and a burgeoning focus on personalized medicine. However, it is not without its challenges, including data security concerns and regulatory complexities. As the industry continues to evolve, stakeholders must remain agile, leveraging innovation and collaboration to unlock the full potential of bioinformatics in shaping the future of life sciences.

Related Reports:

Global Landscape of Lung Cancer Services: Insights and Trends

Monkeypox Unveiled: Symptoms, Transmission, and Preventive Measures

Pneumonia Demystified: Symptoms, Causes, and Prevention Strategies

Understanding Lupus: Navigating the Complex Autoimmune Disorder

Comprehensive Guide to Ringworm: Symptoms, Causes, and Effective Treatment

Comprehensive Guide to Diverticulitis: Symptoms, Causes, and Solutions

Regulatory Insights, Disease Landscape, and Market Access Expertise are some of the areas we help you grasp when it comes to strategic Diabetes Disease consulting.

With specialized market entrance techniques, find solutions to HPV disease. Advice on clinical trials and FDA/EMA insights. Investigate now!

Learn about specialized approaches to market access, pricing, and reimbursement for Pancreatic Cancer Disease. Become knowledgeable about clinical trials and market research. Transform your company right away.

Get market insights on Anemia Disease, including KOLs, the FDA, epidemiology, price reimbursement, and more. Your reliable resource for information about anemia. Investigate now!

Symptoms, prevention, and market research on the Chlamydia Disease. Follow updates from the FDA and EMA, epidemiology research, and market entrance strategies.

the Ovarian Cancer Disease market using our tried-and-true tactic. Learn to identify your product’s important opinion leaders, to negotiate the regulatory process, and to set a fair pricing.

Investigating AI’s Potential to Transform Radiology: Applications AI in Medical Imaging

AI Healthcare Solutions:Addressing Ethical Considerations: Insights and Strategiesm

Top Death Causes Associated with Cancer

A COVID-19 Breakthrough Therapy with Emergency Use Authorization is paxlovid.

Monkeypox and the Top 5 Monkeypox Research Companies

The Power of Tech Innovation: How Technology is Revolutionizing the Entire Drug Discovery Sector

Causes, Treatment, Research, and Leading Companies Fighting Lung Cancer

Money Matters: Increasing Clinical Trial Revenue Strategies by Addressing CRO Challenges

Get involved!

Get Connected!
Connect with like-minded people, start groups, share files and documents, create group video meetings, attend conferences, and more.


No comments yet